Patents by Inventor Herbert Jünger

Herbert Jünger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100057227
    Abstract: An electronic system for modulating audio signals and operating based on a digital signal processing is disclosed. The electronic device includes at least one means for monitoring the parameters operating level and peak level of the audio signal and for automatically adjusting the operating level of the audio signal. Also disclosed is a corresponding computer program for modulating audio signals and a corresponding computer-readable storage medium for storing the computer program.
    Type: Application
    Filed: June 13, 2006
    Publication date: March 4, 2010
    Applicant: Junger Audio-Studiotechnik GMBH
    Inventor: Herbert Jünger
  • Patent number: 7276253
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Grant
    Filed: August 11, 2006
    Date of Patent: October 2, 2007
    Assignee: AstraZeneca AB
    Inventors: Gerd-Ulfert Heese, Herbert Jünger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Patent number: 6623759
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: September 23, 2003
    Assignee: AstraZeneca AB
    Inventors: Gerd-Ulfert Heese, Herbert Jünger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss